Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination
- PMID: 19200845
- PMCID: PMC2693348
- DOI: 10.1016/j.vaccine.2009.01.079
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination
Abstract
The variability of immune response modulated by immune response gene polymorphisms is a significant factor in the protective effect of vaccines. We studied the association between cellular (cytokine) immunity and HLA genes among 738 schoolchildren (396 males and 342 females) between the ages of 11 and 19 years, who received two doses of rubella vaccine (Merck). Cytokine secretion levels in response to rubella virus stimulation were determined in PBMC cultures by ELISA. Cell supernatants were assayed for Th1 (IFN-gamma, IL-2, and IL-12p40), Th2 (IL-4, IL-5, and IL-10), and innate/proinflammatory (TNF-alpha, GM-CSF, and IL-6) cytokines. We found a strong association between multiple alleles of the HLA-DQA1 (global p-value 0.022) and HLA-DQB1 (global p-value 0.007) loci and variations in rubella-specific IL-2 cytokine secretion. Additionally, the relationships between alleles of the HLA-A (global p-value 0.058), HLA-B (global p-value 0.035), and HLA-C (global p-value 0.023) loci and TNF-alpha secretion suggest the importance of HLA class I molecules in innate/inflammatory immune response. Better characterization of these genetic profiles could help to predict immune responses at the individual and population level, provide data on mechanisms of immune response development, and further inform vaccine development and vaccination policies.
Similar articles
-
Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.PLoS One. 2010 Jul 27;5(7):e11806. doi: 10.1371/journal.pone.0011806. PLoS One. 2010. PMID: 20668555 Free PMC article.
-
Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.Clin Vaccine Immunol. 2007 Feb;14(2):115-22. doi: 10.1128/CVI.00247-06. Epub 2007 Jan 10. Clin Vaccine Immunol. 2007. PMID: 17215337 Free PMC article.
-
HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine.Vaccine. 2009 May 26;27(25-26):3349-58. doi: 10.1016/j.vaccine.2009.01.080. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200828 Free PMC article.
-
Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis.Immunobiology. 1999 Dec;201(2):255-71. doi: 10.1016/S0171-2985(99)80066-7. Immunobiology. 1999. PMID: 10631575 Review.
-
Vaccine immunogenetics: bedside to bench to population.Vaccine. 2008 Nov 18;26(49):6183-8. doi: 10.1016/j.vaccine.2008.06.057. Epub 2008 Jul 1. Vaccine. 2008. PMID: 18598732 Free PMC article. Review.
Cited by
-
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.Hum Immunol. 2010 Apr;71(4):383-91. doi: 10.1016/j.humimm.2010.01.004. Epub 2010 Jan 31. Hum Immunol. 2010. PMID: 20079393 Free PMC article.
-
Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.PLoS One. 2010 Jul 27;5(7):e11806. doi: 10.1371/journal.pone.0011806. PLoS One. 2010. PMID: 20668555 Free PMC article.
-
Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts.Immunol Res. 2014 Jan;58(1):1-8. doi: 10.1007/s12026-013-8475-y. Immunol Res. 2014. PMID: 24375276 Free PMC article.
-
Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination.J Infect Dis. 2010 Jan 15;201(2):207-13. doi: 10.1086/649588. J Infect Dis. 2010. PMID: 20001730 Free PMC article.
-
Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed.Infect Immun. 2013 Jul;81(7):2584-91. doi: 10.1128/IAI.00269-13. Epub 2013 May 6. Infect Immun. 2013. PMID: 23649091 Free PMC article. Clinical Trial.
References
-
- Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol. 2004;65:1506–15. - PubMed
-
- Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis. 2005;191(4):515–9. - PubMed
-
- Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system. Hum Immunol. 2002;63(12):1213–68. - PubMed
-
- Tan P-L, Jacobson RM, Poland GA, Jacobsen SJ, Pankratz SV. Twin studies of immunogenicity—determining the genetic contribution to vaccine failure. Vaccine. 2001;19:2434–9. - PubMed
-
- Jacobson RM, Ovsyannikova IG, Targonski PV, Poland GA. Studies of twins in vaccinology. Vaccine. 2007;25(16):3160–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials